Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative.

Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BA.

Gynecol Oncol. 2013 Sep;130(3):403-6. doi: 10.1016/j.ygyno.2013.05.026. Epub 2013 May 26.

3.

Gynecologic oncology quality measures: what really matters?

Chalas E.

Gynecol Oncol. 2013 Sep;130(3):401-2. doi: 10.1016/j.ygyno.2013.07.096. No abstract available.

PMID:
23953769
5.

Improving cancer care through public reporting of meaningful quality measures.

Spinks TE, Walters R, Feeley TW, Albright HW, Jordan VS, Bingham J, Burke TW.

Health Aff (Millwood). 2011 Apr;30(4):664-72. doi: 10.1377/hlthaff.2011.0089.

PMID:
21471487
6.

The Patient Protection and Affordable Care Act: what every provider of gynecologic oncology care should know.

Duska LR, Engelhard CL.

Gynecol Oncol. 2013 Jun;129(3):606-12. doi: 10.1016/j.ygyno.2013.02.036. Epub 2013 Mar 13. Review.

PMID:
23500090
7.

Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.

Rimel BJ, Burke WM, Higgins RV, Lee PS, Lutman CV, Parker L.

Gynecol Oncol. 2015 May;137(2):280-4. doi: 10.1016/j.ygyno.2015.02.021. Epub 2015 Feb 28.

PMID:
25735256
8.

Society of Gynecologic Oncology meeting highlights progress.

Jenks S.

J Natl Cancer Inst. 2011 Apr 6;103(7):533-4. doi: 10.1093/jnci/djr121. Epub 2011 Mar 23. No abstract available.

PMID:
21436060
9.

What constitutes the "optimal" treatment environment of women with gynecologic cancer?

Orr JW Jr.

Gynecol Oncol. 2003 Apr;89(1):1-3. No abstract available.

PMID:
12694646
10.

Performance status and symptom scores of women with gynecologic cancer at the end of life.

Spoozak L, Seow H, Liu Y, Wright J, Barbera L.

Int J Gynecol Cancer. 2013 Jun;23(5):971-8. doi: 10.1097/IGC.0b013e318291e5ef.

PMID:
23666015
11.

Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy.

Khalifa MA, Dodge J, Covens A, Osborne R, Ackerman I.

Gynecol Oncol. 2003 Aug;90(2):425-30.

PMID:
12893212
12.

Trends in gynecologic cancer care in North America.

Reade C, Elit L.

Obstet Gynecol Clin North Am. 2012 Jun;39(2):107-29. doi: 10.1016/j.ogc.2012.02.003. Epub 2012 Apr 6. Review.

PMID:
22640706
13.

Tumor board in gynecologic oncology.

Santoso JT, Schwertner B, Coleman RL, Hannigan EV.

Int J Gynecol Cancer. 2004 Mar-Apr;14(2):206-9.

PMID:
15086716
14.

The gynecologic oncologist and futile therapy in a managed care setting.

Benrubi GI.

Curr Womens Health Rep. 2002 Jun;2(3):159-62. Review.

PMID:
12099189
15.

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review.

Vernooij F, Heintz P, Witteveen E, van der Graaf Y.

Gynecol Oncol. 2007 Jun;105(3):801-12. Epub 2007 Apr 12. Review.

PMID:
17433422
16.

Variation in patient routine costliness in U.S. psychiatric facilities.

Cromwell J, Drozd EM, Gage B, Maier J, Richter E, Goldman HH.

J Ment Health Policy Econ. 2005 Mar;8(1):15-28.

PMID:
15870482
18.

Assessing health-related quality of life in gynecologic oncology.

Nordin AJ, Greimel E; Gynecology Group of the EORTC Quality of Life Group.

Int J Gynecol Cancer. 2010 Nov;20(8):1301. doi: 10.1111/IGC.0b013e3181ecae96. No abstract available.

PMID:
21051967
19.

Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2014. Final rule.

Centers for Medicare & Medicaid Services (CMS), HHS.

Fed Regist. 2013 Aug 6;78(151):47859-934.

20.

Supplemental Content

Support Center